This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Charles River Laboratories International In (CRL)

NYSE: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 128.20M 104.15M 97.87M 109.98M
Operating Gains/Losses -9.30M 18.68M 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -28.09M -19.49M -16.27M 7.67M
(Increase) Decrease in Inventories -2.96M -1.57M 785.00K 3.77M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 4.60M -7.08M -3.26M 2.21M
(Decrease) Increase In Other Current Liabilities 14.82M 9.63M -6.39M -32.06M
(Increase) Decrease In Other Working Capital 7.85M -6.84M -915.00K -8.59M
Other Non-Cash Items 30.70M 4.32M 35.97M 27.31M
Net Cash From Continuing Operations 251.05M 207.14M 208.01M 206.84M
Net Cash From Discontinued Operations 0.00 0.00 -106.00K -1.56M
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 251.05M 207.14M 207.90M 205.28M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -56.92M -39.15M -47.53M -49.14M
Acquisitions -234.27M -29.22M -16.86M 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -1.15M 307.00K 2.79M 5.45M
Cash Provided by Financing Activities
Net Cash From Investing Activities -297.99M -74.05M -54.99M -36.64M
Issuance of Debt 298.92M 511.80M 74.12M 250.71M
Cash Used for Financing Activities
Issuance of Capital Stock 73.69M 93.79M 18.36M 20.62M
Repayment of Long-Term Debt -194.54M -523.30M -140.35M -252.96M
Repurchase of Capital Stock -122.02M -165.93M -64.19M -283.80M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 5.36M -594.00K 940.00K -6.36M
Net Cash From Financing Activities 61.41M -84.24M -111.12M -271.79M
Effect of Exchange Rate Changes -10.38M -2.61M -1.01M -7.11M
Net Change in Cash & Cash Equivalents 4.10M 46.24M 40.78M -110.26M
CRL News

CRL Charles River Laboratories International In

Analysts Ratings for CRL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 5 5 6
Moderate Buy 0 0 0 0
Hold 9 10 11 10
Moderate Sell 0 0 0 0
Strong Sell 1 1 0 0
GET CRL ANALYST REPORT

Brokerage Partners

CRL Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs